Review ArticleReview Article
Open Access

Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council Countries

Mohammed Z. Aljulifi
Saudi Medical Journal May 2021, 42 (5) 481-490; DOI: https://doi.org/10.15537/smj.2021.42.5.20200676

References

  1. 1.↵
    1. Ogurtsova K,
    2. da Rocha Fernandes JD,
    3. Huang Y,
    4. Linnenkamp U,
    5. Guariguata L,
    6. Cho NH, et al.
    IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40–50.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Al Dawish MA,
    2. Robert AA,
    3. Braham R,
    4. Al Hayek AA,
    5. Al Saeed A,
    6. Ahmed RA, et al.
    Diabetes mellitus in Saudi Arabia: A review of the recent literature. Curr Diabetes Rev 2016; 12: 359–368.
    OpenUrl
  3. 3.↵
    1. Zabetian A,
    2. Kelli HM,
    3. Echouffo-Tcheugui JB,
    4. Narayan KM,
    5. Ali MK.
    Diabetes in the Middle East and North Africa. Diabetes Res Clin Pract 2013; 101: 106–122.
    OpenUrlPubMed
  4. 4.↵
    1. Alkandari A,
    2. Alarouj M,
    3. Elkum N,
    4. Sharma P,
    5. Devarajan S,
    6. Abu-Farha M, et al.
    Adult diabetes and prediabetes prevalence in Kuwait: Data from the Cross-Sectional Kuwait Diabetes Epidemiology Program. J Clin Med 2020; 9: 3420.
    OpenUrl
  5. 5.↵
    1. Hu FB.
    Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids 2003; 38: 103–108.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Hirschhorn JN.
    Genetic epidemiology of type 1 diabetes. Pediatr Diabetes 2003; 4: 87–100.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Alhyas L,
    2. McKay A,
    3. Majeed A.
    Prevalence of Type 2 Diabetes in the States of The Co-Operation Council for the Arab States of the Gulf: A Systematic Review. PLoS One 2012; 7: e40948.
    OpenUrlCrossRefPubMed
  8. 8.
    1. Knip M,
    2. Veijola R,
    3. Virtanen SM,
    4. Hyöty H,
    5. Vaarala O,
    6. Akerblom HK.
    Environmental triggers and determinants of type 1 diabetes. Diabetes 2005; 54 Suppl 2: S125–S136.
    OpenUrl
  9. 9.
    1. Jeon CY,
    2. Lokken RP,
    3. Hu FB,
    4. van Dam RM.
    Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care 2007; 30: 744–752.
    OpenUrlAbstract/FREE Full Text
  10. 10.
    1. Willi C,
    2. Bodenmann P,
    3. Ghali WA,
    4. Faris PD,
    5. Cornuz J.
    Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007; 298: 2654–2664.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Montonen J,
    2. Knekt P,
    3. Järvinen R,
    4. Aromaa A,
    5. Reunanen A.
    Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr 2003; 77: 622–629.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Standards of Medical Care in Diabetes. Diabetes Care 2004; 27 (Suppl 1): s15–s35.
    OpenUrlFREE Full Text
  13. 13.↵
    1. Morgan SA,
    2. Ali MM,
    3. Channon AA,
    4. Al-Sabahi S,
    5. Al Suwaidi H,
    6. Osman N, et al.
    Prevalence and correlates of diabetes and its comorbidities in four Gulf Cooperation Council countries: evidence from the World Health Survey Plus. J Epidemiol Community Health 2019; 73: 630–636.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Alhyas L,
    2. McKay A,
    3. Balasanthiran A,
    4. Majeed A.
    Prevalences of overweight, obesity, hyperglycaemia, hypertension and dyslipidaemia in the Gulf: systematic review. JRSM Short Rep 2011; 2: 55.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Després JP,
    2. Lemieux I.
    Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–887.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Gazzaz ZJ,
    2. Iftikhar R,
    3. Jameel T,
    4. Baig M,
    5. Murad MA.
    Association of dyslipidemia and comorbidities with risk factors among diabetic patients: A retrospective analysis. Diabetes Metab Syndr Obes 2020; 13: 935–941.
    OpenUrl
  17. 17.↵
    Collaborators GRF. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1659–1724.
    OpenUrlCrossRefPubMed
  18. 18.↵
    International Diabetes Federation. IDF Diabetes Atlas,. 9th ed Brussels, Belgium: International Diabetes Fedration; 2019.
  19. 19.↵
    1. Al-Rubeaan K.
    The impact of diabetes mellitus on health and economy of Gulf Cooperation Council countries. Diabetes Manage 2014; 4: 381–390.
    OpenUrl
  20. 20.↵
    Alpen Capita Co. GCC health care industry. March 26, 2018. Available from: http://www.alpencapital.com/downloads/reports/2018/GCC-Healthcare-Industry-Report-March-2018.pdf
  21. 21.↵
    World Health Organization. Bahrain health profile 2015. Geneva (SW): World Health Organization, Regional Office for the Eastern Mediterranean; 2017.
  22. 22.↵
    1. Alhyas L,
    2. McKay A,
    3. Majeed A.
    Prevalence of type 2 diabetes in the States of the cooperation council for the Arab States of the Gulf: a systematic review. PLoS One 2012; 7: e40948.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Al-Rifai R,
    2. Majeed M,
    3. Qambar M,
    4. Ibrahim A,
    5. AlYammahi K,
    6. Aziz F.
    Type 2 diabetes and pre-diabetes mellitus: a systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000-2018. Syst Rev 2019; 8: 268.
    OpenUrlPubMed
  24. 24.↵
    1. Alotaibi A,
    2. Perry L,
    3. Gholizadeh L,
    4. Al-Ganmi A.
    Incidence and prevalence rates of diabetes mellitus in Saudi Arabia: An overview. J Epidemiol Glob Health 2017; 7: 211–218.
    OpenUrl
  25. 25.↵
    1. Al Quwaidhi A.
    Epidemiological modelling of type 2 diabetes in Saudi Arabia: predicted trends and public health implications. Tyne (UK): Newcastle University; 2013.
  26. 26.↵
    1. Al-Lawati JA,
    2. Panduranga P,
    3. Al-Shaikh HA,
    4. Morsi M,
    5. Mohsin N,
    6. Khandekar RB, et al.
    Epidemiology of Diabetes Mellitus in Oman: Results from two decades of research. Sultan Qaboos University Medical Journal 2015; 15: e226–e233.
    OpenUrl
  27. 27.↵
    1. Awad SF,
    2. O’Flaherty M,
    3. Critchley J,
    4. Abu-Raddad LJ.
    Forecasting the burden of type 2 diabetes mellitus in Qatar to 2050: A novel modeling approach. Diabetes Res Clin Pract 2018; 137: 100–108.
    OpenUrlPubMed
  28. 28.↵
    International Diabetes Federation. Diabetes Atlas 2000. [cited 2020]. Available from: https://idf.org/e-library/epidemiology-research/diabetes-atlas.html
  29. 29.
    1. Gan D.
    Diabetes atlas. Brussels (BL): International Diabetes Federation; 2003.
  30. 30.
    1. Mbyana J,
    2. Gan D,
    3. Allgot B,
    4. Bakker K,
    5. Brown J,
    6. Ramachandran A.
    Diabetes Atlas. Brussels: International Diabetes Federation; 2006.
  31. 31.
    1. Unwin N,
    2. Whiting D,
    3. Gan D,
    4. Jacqmain O,
    5. Ghyoot G.
    Diabetes Atlas. Brussels: International Diabetes Federation; 2009.
  32. 32.
    1. Aguiree F,
    2. Brown A,
    3. Cho N,
    4. Dahlquist G,
    5. Dodd S,
    6. Dunning T, et al.
    Diabetes Atlas. Brussels: International Diabetes Federation; 2013.
  33. 33.
    International Diabetes Federation. Diabetes Atlas, 7th ed. Brussels: International Diabetes Federation; 2015.
  34. 34.↵
    International Diabetes Federation. Electronic resource. Brussels: International Diabetes Federation; 2017.
  35. 35.↵
    United Nations Development Programme. Human development index. [cited 2019]. Available from: http://hdr.undp.org/sites/default/files/hdr2019.pdf
  36. 36.↵
    1. Boutayeb A,
    2. Lamlili M,
    3. Boutayeb W,
    4. Maamri A,
    5. Ziyyat A,
    6. Ramdani N.
    The rise of diabetes prevalence in the Arab region. Open Journal of Epidemiology 2012; 2: 55–60.
    OpenUrl
  37. 37.↵
    World Health Organization. Obesity and overweight. [cited 2020 March 3]. Available from: https://www.who.int/news-room/fact-sheets/obesity-and-overweight
  38. 38.↵
    1. Banjare J,
    2. Bhalerao S.
    Obesity associated noncommunicable disease burden. International Journal of Health & Allied Sciences 2016; 5: 81.
    OpenUrl
  39. 39.↵
    1. Dillinger J.
    The most obese countries in the world. [cited 2018 February 16]. Available from: https://www.worldatlas.com/articles/29-most-obese-countries-in-the-world.html.
  40. 40.↵
    1. Weiderpass E,
    2. Botteri E,
    3. Longenecker JC,
    4. Alkandari A,
    5. Al-Wotayan R,
    6. Al Duwairi Q, et al.
    The prevalence of overweight and obesity in an adult Kuwaiti population in 2014. Front Endocrinol (Lausanne) 2019; 10: 449.
    OpenUrl
  41. 41.
    al-Awadi F, Amine EK. Overweight and obesity in Kuwait. J R Soc Health 1989; 109: 175–177.
    OpenUrlPubMedWeb of Science
  42. 42.↵
    1. Al-Duwairi Q.
    Eastern Mediterranean Approach for Control of Non Communicable Diseases: Ministry of Health in the State of Kuwait [cited 2015]. Available from: https://www.who.int/ncds/surveillance/steps/Kuwait_2014_STEPS_Report.pdf.
  43. 43.↵
    1. Al-Quwaidhi AJ,
    2. Pearce MS,
    3. Critchley JA,
    4. Sobngwi E,
    5. O’Flaherty M.
    Trends and future projections of the prevalence of adult obesity in Saudi Arabia, 1992-2022. East Mediterr Health J 2014; 20: 589–595.
    OpenUrlPubMed
  44. 44.↵
    1. Balhareth A,
    2. Meertens R,
    3. Kremers S,
    4. Sleddens E.
    Overweight and obesity among adults in the Gulf States: A systematic literature review of correlates of weight, weight-related behaviours, and interventions. Obesity Reviews 2019; 20: 763–793.
    OpenUrl
  45. 45.↵
    1. Mamtani R,
    2. Lowenfels A.
    Critical Issues in Healthcare Policy and Politics in the Gulf Cooperation Council States: Georgetown University Press; 2018.
  46. 46.↵
    The World Bank. Data Bank, World Development Indicators 2019. [cited 2019]. Available from: https://databank.worldbank.org/home.aspx
  47. 47.↵
    World Health Organization. Global Health Expenditure Database [cited 2020]. Available from: https://apps.who.int/nha/database.
  48. 48.↵
    American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care 2018; 41: 917–928.
    OpenUrl
  49. 49.↵
    1. Almutairi N,
    2. Alkharfy KM.
    Direct medical cost and glycemic control in type 2 diabetic Saudi patients. Appl Health Econ Health Policy 2013; 11: 671–675.
    OpenUrl
  50. 50.↵
    1. Mokdad A,
    2. Tuffaha M,
    3. Hanlon M,
    4. El Bcheraoui C,
    5. Daoud F,
    6. Al Saeedi M, et al.
    Cost of diabetes in the Kingdom of Saudi Arabia, 2014. J Diabetes Metab 2015; 6: 2.
    OpenUrl
  51. 51.↵
    1. Mabry R,
    2. Reeves M,
    3. Eakin E,
    4. Owen N.
    Evidence of physical activity participation among men and women in the countries of the Gulf Cooperation Council: a review. Obes Rev 2010; 11: 457–464.
    OpenUrlPubMed
  52. 52.↵
    1. Al-Nozha M,
    2. Al-Hazzaa H,
    3. Arafah M,
    4. Al-Khadra A,
    5. Al-Mazrou YY,
    6. Al-Maatouq M, et al.
    Prevalence of physical activity and inactivity among Saudis aged 30-70 years. Saudi Med J 2007; 28: 559–568.
    OpenUrlAbstract/FREE Full Text
  53. 53.↵
    1. Mabry R,
    2. Koohsari MJ,
    3. Bull F,
    4. Owen N.
    A systematic review of physical activity and sedentary behaviour research in the oil-producing countries of the Arabian Peninsula. BMC Public Health 2016; 16: 1003.
    OpenUrlPubMed
  54. 54.↵
    1. Alarouj M,
    2. Bennakhi A,
    3. Alnesef Y,
    4. Sharifi M,
    5. Elkum N.
    Diabetes and associated cardiovascular risk factors in the State of Kuwait: the first national survey. Int J Clin Pract 2013; 67: 89–96.
    OpenUrl
  55. 55.↵
    1. Mabry RM,
    2. Morsi M,
    3. Owen N.
    Descriptive epidemiology of sitting time in omani men and women: A known risk factor for non-communicable diseases. Oman Med J 2017; 32: 233–239.
    OpenUrl
  56. 56.↵
    1. Roser M,
    2. Ritchie H.
    Food per Person. [cited 2019]. Available from: https://ourworldindata.org/food-per-person.
  57. 57.↵
    1. Al-Thani M,
    2. Al-Thani AA,
    3. Al-Mahdi N,
    4. Al-Kareem H,
    5. Barakat D,
    6. Al-Chetachi W, et al.
    An overview of food patterns and diet quality in Qatar: Findings from the National Household Income Expenditure Survey. Cureus 2017; 9: e1249.
    OpenUrl
  58. 58.↵
    1. Al-Yateem N,
    2. Rossiter R.
    Nutritional knowledge and habits of adolescents aged 9 to 13 years in Sharjah, United Arab Emirates: a cross-sectional study. East Mediterr Health J 2017; 23: 551–558.
    OpenUrl
  59. 59.↵
    1. Musaiger AO,
    2. Al-Hazzaa HM.
    Prevalence and risk factors associated with nutrition-related noncommunicable diseases in the Eastern Mediterranean region. Int J Gen Med 2012; 5: 199–217.
    OpenUrlPubMed
  60. 60.↵
    1. Chiang JL,
    2. Maahs DM,
    3. Garvey KC,
    4. Hood KK,
    5. Laffel LM,
    6. Weinzimer SA, et al.
    Type 1 diabetes in children and adolescents: A position statement by the American Diabetes Association. Diabetes Care 2018; 41: 2026–2044.
    OpenUrlFREE Full Text
  61. 61.↵
    1. Dabelea D,
    2. Mayer-Davis EJ,
    3. Saydah S,
    4. Imperatore G,
    5. Linder B,
    6. Divers J, et al.
    Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014; 311: 1778–17786.
    OpenUrlCrossRefPubMedWeb of Science
  62. 62.↵
    1. Al-Agha A,
    2. Ocheltree A,
    3. Shata N.
    Prevalence of hyperinsulinism, type 2 diabetes mellitus and metabolic syndrome among Saudi overweight and obese pediatric patients. Minerva Pediatr 2012; 64: 623–631.
    OpenUrlPubMed
  63. 63.↵
    1. Punnose J,
    2. Agarwal M,
    3. Bin Uthman S.
    Type 2 diabetes mellitus among children and adolescents in Al-Ain: a case series. The Eastern Mediterranean Health Journal 2005; 11: 788–797.
    OpenUrl
  64. 64.↵
    1. Moussa M,
    2. Alsaeid M,
    3. Abdella N,
    4. Refai T,
    5. Al-Sheikh N,
    6. Gomez J.
    Prevalence of type 2 diabetes mellitus among Kuwaiti children and adolescents. Med Princ Pract 2008; 17: 270–275.
    OpenUrlPubMed
  65. 65.↵
    1. Alyafei F,
    2. Soliman A,
    3. Alkhalaf F,
    4. Sabt A,
    5. De Sanctis V,
    6. Waseef R, et al.
    Incidence of type 1 and type 2 diabetes, between 2012-2016, among children and adolescents in Qatar. Acta Biomed 2018; 89 (Suppl 5): 7.
    OpenUrl
  66. 66.↵
    1. Ahlqvist E,
    2. Ahluwalia TS,
    3. Groop L.
    Genetics of type 2 diabetes. Clin Chem 2011; 57: 241–254.
    OpenUrlAbstract/FREE Full Text
  67. 67.↵
    1. Sherif S,
    2. Sumpio BE.
    Economic development and diabetes prevalence in MENA countries: Egypt and Saudi Arabia comparison. World J Diabetes 2015; 6: 304–311.
    OpenUrlPubMed
  68. 68.↵
    1. Bennet L,
    2. Groop L,
    3. Lindblad U,
    4. Agardh C,
    5. Franks P.
    Ethnicity is an independent risk indicator when estimating diabetes risk with FINDRISC scores: a cross sectional study comparing immigrants from the Middle East and native Swedes. Prim Care Diabetes 2014; 8: 231–238.
    OpenUrl
  69. 69.↵
    1. Gosadi IM,
    2. Goyder EC,
    3. Teare MD.
    Investigating the potential effect of consanguinity on type 2 diabetes susceptibility in a Saudi population. Hum Hered 2014; 77: 197–206.
    OpenUrlCrossRef
  70. 70.↵
    1. Alsmadi O,
    2. Al-Rubeaan K,
    3. Mohamed G,
    4. Alkayal F,
    5. Al-Saud H,
    6. Al-Saud NA, et al.
    Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population. BMC Med Genet 2008; 9: 72.
    OpenUrlCrossRefPubMed
  71. 71.↵
    1. Wakil SM,
    2. Al-Rubeaan K,
    3. Alsmadi O,
    4. Imtiaz F,
    5. Carroll P,
    6. Rajab M, et al.
    The peroxisome proliferator-activated receptor- 2 P12A polymorphism and type 2 diabetes in an Arab Population. Diabetes Care 2005; 29: 171–172.
    OpenUrl
  72. 72.↵
    1. Alsmadi O,
    2. Al-Rubeaan K,
    3. Wakil SM,
    4. Imtiaz F,
    5. Mohamed G,
    6. Al-Saud H, et al.
    Genetic study of Saudi diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Diabetes Metab Res Rev 2008; 24: 137–140.
    OpenUrlCrossRefPubMed
  73. 73.↵
    1. Siddiqui K,
    2. Musambil M,
    3. Usmani AM.
    Established type 2 diabetes-susceptibility genetic variants in Saudi ethnicity: a mini-systematic review. Journal of Biochemical and Clinical Genetics 2018; 1: 57–65.
    OpenUrl
  74. 74.↵
    1. Al-Daghri NM,
    2. Alkharfy KM,
    3. Al-Attas OS,
    4. Krishnaswamy S,
    5. Mohammed AK,
    6. Albagha OM, et al.
    Association between type 2 diabetes mellitus-related SNP variants and obesity traits in a Saudi population. Mol Biol Rep 2014; 41: 1731–1740.
    OpenUrl
  75. 75.↵
    1. Saadi H,
    2. Nagelkerke N,
    3. Carruthers SG,
    4. Benedict S,
    5. Abdulkhalek S,
    6. Reed R, et al.
    Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects. Diabetes Res Clin Pract 2008; 80: 392–398.
    OpenUrlCrossRefPubMedWeb of Science
  76. 76.↵
    1. Osman W,
    2. Tay GK,
    3. Alsafar H.
    Multiple genetic variations confer risks for obesity and type 2 diabetes mellitus in arab descendants from UAE. Int J Obes (Lond) 2018; 42: 1345–1353.
    OpenUrlCrossRef
  77. 77.↵
    1. O’Beirne S,
    2. Salit J,
    3. Rodriguez-Flores J,
    4. Staudt M,
    5. Khalil C,
    6. Fakhro K, et al.
    Type 2 diabetes risk allele loci in the Qatari population. PloS One 2016; 11: e0156834.
    OpenUrl
  78. 78.↵
    1. Al Hannan F,
    2. O’Farrell P,
    3. Morgan MP,
    4. Tighe O,
    5. Culligan KG.
    Associations between single-nucleotide polymorphisms of ADIPOQ, serum adiponectin and increased type 2 diabetes mellitus risk in Bahraini individuals. East Mediterr Health J 2016; 22: 611–618.
    OpenUrl
  79. 79.↵
    1. Al-Serri A,
    2. Ismael F,
    3. Al-Bustan S,
    4. Al-Rashdan I.
    Association of the insertion allele of the common ACE gene polymorphism with type 2 diabetes mellitus among Kuwaiti cardiovascular disease patients. J Renin Angiotensin Aldosterone Syst 2015; 16: 910–916.
    OpenUrlCrossRefPubMed
  80. 80.↵
    American Diabetes Association. Lifestyle Management: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41 (Suppl 1): S38–S50.
    OpenUrlAbstract/FREE Full Text
  81. 81.
    1. Luo L,
    2. Pang B,
    3. Chen J,
    4. Li Y,
    5. Xie X.
    Assessing the Impact of Lifestyle Interventions on Diabetes Prevention in China: A Modeling Approach. Int J Environ Res Public Health 2019; 16: 1677.
    OpenUrl
  82. 82.
    1. Wharton S,
    2. Pedersen SD,
    3. Lau DCW,
    4. Sharma AM.
    Weight Management in Diabetes. Can J Diabetes 2018; 42 Suppl 1: S124–S129.
    OpenUrl
  83. 83.↵
    1. Saboo B,
    2. Joshi S,
    3. Shah SN,
    4. Tiwaskar M,
    5. Vishwanathan V,
    6. Bhandari S, et al.
    Management of diabetes during fasting and feasting in India. J Assoc Physicians India 2019; 67: 70–77.
    OpenUrl
  84. 84.↵
    1. Veerman JL,
    2. Sacks G,
    3. Antonopoulos N,
    4. Martin J.
    The Impact of a Tax on Sugar-Sweetened Beverages on Health and Health Care Costs: A Modelling Study. PLoS One 2016; 11: e0151460.
    OpenUrlPubMed
  85. 85.↵
    . American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43 (Suppl 1): S14–S31.
    OpenUrlAbstract/FREE Full Text
  86. 86.↵
    1. Sulaiman N,
    2. Mahmoud I,
    3. Hussein A,
    4. Elbadawi S,
    5. Abusnana S,
    6. Zimmet P, et al.
    Diabetes risk score in the United Arab Emirates: a screening tool for the early detection of type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2018; 6: e000489.
    OpenUrlAbstract/FREE Full Text
  87. 87.↵
    Association AD. Improving care and promoting health in populations: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43 (Supplement 1): S7–S13.
    OpenUrlFREE Full Text
  88. 88.↵
    1. Wan EYF,
    2. Fung CSC,
    3. Jiao FF,
    4. Yu EYT,
    5. Chin WY,
    6. Fong DYT, et al.
    Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses-A Population-Based and Propensity-Matched Cohort Study. Diabetes Care 2018; 41: 49–59.
    OpenUrlAbstract/FREE Full Text
  89. 89.↵
    1. Pitchika A,
    2. Vehik K,
    3. Hummel S,
    4. Norris JM,
    5. Uusitalo UM,
    6. Yang J, et al.
    Associations of Maternal Diabetes During Pregnancy with Overweight in Offspring: Results from the Prospective TEDDY Study. Obesity (Silver Spring, Md) 2018; 26: 1457–1466.
    OpenUrl
  90. 90.↵
    1. Le Moullec N,
    2. Fianu A,
    3. Maillard O,
    4. Chazelle E,
    5. Naty N,
    6. Schneebeli C, et al.
    Sexual dimorphism in the association between gestational diabetes mellitus and overweight in offspring at 5-7 years: The OBEGEST cohort study. PLoS One 2018; 13: e0195531.
    OpenUrlCrossRefPubMed
  91. 91.↵
    1. Abualhamael S,
    2. Mosli H,
    3. Baig M,
    4. Noor AM,
    5. Alshehri FM.
    Prevalence and Associated Risk Factors of Gestational Diabetes Mellitus at a University Hospital in Saudi Arabia. Pak J Med Sci 2019; 35: 325–329.
    OpenUrl
  92. 92.↵
    1. Groof Z,
    2. Garashi G,
    3. Husain H,
    4. Owayed S,
    5. AlBader S,
    6. Mouhsen H, et al.
    Prevalence, risk factors, and fetomaternal outcomes of gestational diabetes mellitus in Kuwait: A cross-sectional study. J Diabetes Res 2019; 2019: 9136250.
    OpenUrl
  93. 93.↵
    1. Bogari NM.
    Genetic construction between polycystic ovarian syndrome and type 2 diabetes. Saudi J Biol Sci 2020; 27: 2539–2543.
    OpenUrl
  94. 94.↵
    1. Dargham SR,
    2. Shewehy AE,
    3. Dakroury Y,
    4. Kilpatrick ES,
    5. Atkin SL.
    Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome. Sci Rep 2018; 8: 3619.
    OpenUrlPubMed
  95. 95.↵
    1. Lin PJ,
    2. Kent DM,
    3. Winn A,
    4. Cohen JT,
    5. Neumann PJ.
    Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. Am J Manag Care 2015; 21: e23–e34.
    OpenUrlPubMed
  96. 96.↵
    1. Iglay K,
    2. Hannachi H,
    3. Joseph Howie P,
    4. Xu J,
    5. Li X,
    6. Engel SS, et al.
    Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin 2016; 32: 1243–1252.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords